Enjoy complimentary customisation on priority with our Enterprise License!
The orthopedic soft tissue repair devices market size is forecast to increase by USD 6.39 billion at a CAGR of 11.28% between 2023 and 2028. The market is witnessing significant growth due to several key trends and factors. The aging population demographic, with its increasing prevalence across the globe, is a major driving force for market expansion. This demographic shift is leading to a higher incidence of orthopedic conditions and subsequent demand for soft tissue repair devices. Additionally, the growing use of orthopedic devices in emerging markets, such as Asia-Pacific and Latin America, presents new opportunities for market growth. Furthermore, the high cost of orthopedic procedures and procedures is fueling the adoption of less invasive soft tissue repair devices, which offer cost savings and faster recovery times.
These factors collectively contribute to the strong growth of the market.
The global orthopedic soft tissue repair market is expected to experience significant growth due to the increasing prevalence of soft tissue injuries caused by obesity and trauma accidents. According to the Centers for Disease Control and Prevention (CDC), obesity rates have more than doubled in the past few decades, leading to an increase in musculoskeletal injuries. In addition, the number of emergency room visits due to sports-related injuries, such as ACL injuries in athletes, is on the rise. The market is witnessing innovation in the form of biological meshes, bioprinting, and biofabrication for the repair of soft tissue injuries.
These advanced technologies offer advantages such as faster healing, reduced scarring, and improved functionality. The hip application segment is expected to dominate the market due to the high prevalence of hip joint dysfunction, hip impingement, labral tears, and cruciate ligaments repair. Other areas of growth include rotator cuff repair, epicondylitis, Achilles tendinosis repair, pelvic organ prolapse, osteoporosis, osteoarthritis, and gluteal tendon repair. The use of personal protective equipment is also expected to increase to prevent soft tissue injuries. Overall, the market is expected to grow steadily due to the increasing incidence of soft tissue injuries and the development of advanced repair technologies.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD billion" for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.
The fixation devices segment is estimated to witness significant growth during the forecast period. Soft tissue injuries, a common consequence of obesity rate and trauma accidents, can lead to various musculoskeletal disorders. These injuries often affect the cruciate ligaments in the knee, rotator cuffs in the shoulder, and weakened ligaments in small joints. Biological meshes, such as collagen and synthetic scaffolds, are increasingly used for soft tissue repair, enabling faster healing and reducing the need for invasive treatment. Bioprinting and biofabrication are emerging technologies in orthopedics, offering potential solutions for complex tissue repair, including neuromuscular training programs for athletes and arthritis patients. Fixation devices, including suture anchors and interference screws, play a vital role in repairing damaged soft tissues, such as ACL tears, epicondylitis, and Achilles tendinosis.
Minimally invasive treatment, like hip arthroscopy and biceps tenodesis, are increasingly popular for reconstructing damaged joints, particularly in the geriatric population. Sternal closure devices and gluteal tendon repair are other applications of fixation devices. Musculoskeletal injuries, including hip impingement, labral tears, and meniscus damage, can significantly impact a person's quality of life, making the development of effective repair solutions a priority in medical devices.
Get a glance at the market share of various segments Request Free Sample
The fixation devices segment accounted for USD 3.54 billion in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 45% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The market witnessed substantial revenue generation in North America in 2022, driven by the increase in trauma cases, including knee arthroscopies and an increasing number of amputations and sports-related injuries. According to the Osteoarthritis Research Society International, approximately 700,000 of the 1 million knee arthroscopies carried out in the US annually focus on the meniscus. This region's growth can be attributed to rising healthcare expenditures and infrastructure investments, which help reduce the cost of intricate orthopedic soft tissue repair. Degenerative musculoskeletal conditions, such as osteoarthritis, and minimally invasive procedures further fuel the market's expansion in North America. Personal Protective Equipment (PPE) usage remains crucial during these procedures to ensure the safety of both patients and healthcare professionals.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The rising geriatric population globally is the key driver of the market. The global market is experiencing significant growth due to the increasing prevalence of musculoskeletal disorders among the geriatric population. Older adults are more susceptible to soft tissue injuries caused by obesity, trauma accidents, and musculoskeletal conditions such as arthritis, weakening ligaments, and cruciate ligament tears. These injuries can lead to invasive for reconstruction procedures, including ACL tears, rotator cuff repair, hip arthroscopy, biceps tenodesis, and meniscus repair. Advancements in medical devices, such as biological meshes, biofabrication, and neuromuscular training programs, are enabling minimally invasive for various conditions, including hip impingement, labral tears, hip fractures, osteoporosis, and pelvic organ prolapse.
Additionally, soft tissue injuries in athletes, such as epicondylitis, Achilles tendinosis repair, and gluteal tendon repair, are also driving market growth. The rising number of knee ligament injuries and knee injuries, particularly in sports-related activities, is also contributing to market expansion. The increasing use of minimally invasive, such as hip arthroscopies, is expected to further boost market growth. Furthermore, the development of new technologies, including bioprinting, is expected to revolutionize the market in the coming years. Despite these advancements, the challenge of making up for the limitations caused by soft tissue injuries and resuming daily activities, particularly in older adults, remains a significant concern.
The slow healing process and muscle weakness that result from immobility and inactivity can lead to permanent tissue damage and scarring. These factors are driving the demand for effective and innovative orthopedic soft tissue repair devices.
Growing use of orthopedic devices in emerging market is the upcoming trend in the market. The global market is poised for significant growth in the upcoming years, particularly in emerging economies in Asia and the Rest of the World (ROW). Factors driving this growth include a substantial patent base for target indications such as musculoskeletal disorders, obesity-related injuries from trauma accidents, and neuromuscular training programs for athletes. Additionally, an increasing geriatric population, rising healthcare expenditure, and growing health awareness are contributing to market expansion. Advancements in technology, including biological meshes, bioprinting, and biofabrication, are revolutionizing soft tissue repair procedures for various conditions such as ACL tears, rotator cuff repair, epicondylitis, Achilles tendinosis repair, pelvic organ prolapse, and gluteal tendon repair.
Minimally invasive treatments, such as hip arthroscopy, biceps tenodesis, and cruciate ligaments repair, are becoming increasingly popular due to their reduced recovery time and lower risk of complications compared to invasive. Key indications for orthopedic soft tissue repair devices include meniscus injuries, hip joint dysfunction, labral tears, and hip impingement. These conditions affect small joints in the knee, shoulder, and other areas and can result from sports-related injuries, arthritis, osteoporosis, or weakening of ligaments. The market for these devices is expected to grow rapidly due to the high prevalence of musculoskeletal injuries and the increasing demand for effective and minimally invasive treatment options.
In summary, the global market is experiencing significant growth due to a combination of factors, including technological advancements, an aging population, and increasing healthcare expenditure. The market is expected to expand significantly in emerging economies, particularly in Asia and the Rest of the World, due to a large patient base, growing health awareness, and developing healthcare infrastructure. The market is also being driven by the development of innovative products and procedures for the repair of various soft tissue injuries, including those affecting the knee, shoulder, and hip.
High cost of orthopedic procedures is a key challenge affecting the market growth. The global orthopedic soft tissue repair market is witnessing significant growth due to the increasing prevalence of soft tissue injuries caused by obesity, trauma accidents, and musculoskeletal disorders. These injuries include ACL tears, rotator cuff repair, epicondylitis, Achilles tendinosis repair, pelvic organ prolapse, gluteal tendon repair, and cruciate ligaments repair, among others. The geriatric population is particularly vulnerable to hip joint dysfunction, hip impingement, labral tears, hip arthroscopy, meniscus injuries, and knee arthroscopies. Orthopedic soft tissue repair devices include biological meshes, bioprinting, and biofabrication, which are increasingly being used in minimally invasive devices. Neuromuscular training programs and invasive are also common for treating musculoskeletal injuries.
The high cost of invasive devices and medical devices, which can range from USD 25,000 to USD 50,000 in the US, including consultation fees and post-surgical care, poses a significant challenge to the market growth. However, the advancements in technology, such as bioprinting and biofabrication, are expected to reduce the cost and increase the accessibility of these devices. The market is also witnessing an increasing demand for devices used in reconstructive procedures for sports-related injuries, such as knee ligament injuries and shoulder injuries.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Acera Surgical Inc. - The company provides orthopedic soft tissue repair solutions, specifically the AlloConnex device, which caters to a diverse array of procedures.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The global market is witnessing significant growth due to the rising prevalence of soft tissue injuries caused by obesity, trauma accidents, and musculoskeletal disorders. Obesity rate is a major factor contributing to the increase in soft tissue injuries, particularly in the knee and hip joints. Biological meshes, bioprinting, and biofabrication are emerging technologies in the field of orthopedic soft tissue repair, offering advantages such as faster healing and reduced scarring. Athletes and individuals with arthritis, weakened ligaments, ACL tears, and hip fractures are prime candidates for these advanced repair techniques. Neuromuscular training programs, osteoporosis, and hip impingement are other conditions driving market growth.
Reconstruction procedures for cruciate ligaments, rotator cuff repair, epicondylitis, Achilles tendinosis repair, pelvic organ prolapse, and gluteal tendon repair are common applications for orthopedic soft tissue repair devices. Minimally invasive, such as hip arthroscopy and knee arthroscopies, are increasingly popular due to their shorter recovery time and reduced risk of complications. Invasive is still required for complex injuries and conditions, such as meniscus tears, labral tears, and hip joint dysfunction. The geriatric population is another significant market segment due to the high prevalence of musculoskeletal injuries and disorders in this demographic. Small joints and shoulders are also gaining attention in the market due to the increasing incidence of sports-related injuries.
Market Scope |
|
Report Coverage |
Details |
Page number |
168 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 11.28% |
Market growth 2024-2028 |
USD 6.39 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
10.79 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 45% |
Key countries |
US, Germany, France, UK, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Acera Surgical Inc., AlloSource, Amplitude SAS, Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Zimmer Biomet Holdings Inc., and Arthrex Inc. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.